Investigating Potential Claims involving Protea Biosciences Group
The White Law Group is investigating potential claims involving broker-dealers who may have unsuitably recommended Protea Biosciences Group to investors.
Protea Biosciences Group, Inc., a molecular information company, provides proprietary, bioanalytical workflows to the pharmaceutical and life science industries. The company was founded in 2001 and is based in Morgantown, West Virginia.
According to SEC filings, on 11/14/2017, Protea Biosciences Group announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Protoea filed a Form D to raise capital in 2015. Reg D private placement investments such as this are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as Protea Biosciences Group is that they involve a high degree of risk. Private placement investments are typically sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds. These investments may seem wise at first, until the dramatic drop in distributions.
Recovery of Investment Losses
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly selling high-risk private placements, like Protea Biosciences Group to their clients.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
Did you lose money investing in Protea Biosciences Group at the recommendation of your financial advisor? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration Claim against the brokerage firm that sold you the investment.
FINRA operates the largest securities dispute resolution forum in the United States, and has extensive experience in providing a fair, efficient and effective venue to handle a securities-related dispute.
Please call The White Law Group at 888-637-5510 for a free consultation.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: Protea Biosciences Group, Protea Biosciences Group class action, Protea Biosciences Group complaints, Protea Biosciences Group help, Protea Biosciences Group investment, Protea Biosciences Group investment losses, Protea Biosciences Group investor relations, Protea Biosciences Group investors, Protea Biosciences Group litigation, Protea Biosciences Group losses, Protea Biosciences Group private placement, Protea Biosciences Group recovery options, Protea Biosciences Group risk, Protea Biosciences Group update, Protea Biosciences Group value, Protea Biosciences Group information, Protea Biosciences Group investigation, Protea Biosciences Group ppm, Protea Biosciences Group prospectus Last modified: December 6, 2017